1f
12
9
1a
8
20
8
49
16
8
19
1
49
2
8
1b
1d
18
89
35
1d
2 29
1d
25
35
Laura A Adang, M.D., PhD
70Assistant Professor of Neurology at the Children's Hospital of Philadelphia
7
60
Department: Neurology
4
1
b
1d
46
Contact information
55
4
3
3
3
2
4
b
1f
55
The Children's Hospital of Philadelphia
33 3400 Civic Blvd.
Philadelphia, PA 19104
26
33 3400 Civic Blvd.
Philadelphia, PA 19104
2e
Office: 215-590-1710
30
8b
30
Email:
adangl@email.chop.edu
12
adangl@email.chop.edu
13
Education:
21 7 BS 4f (Interdisciplinary Studies: Neurology - Magna cum laude with Honors) c
2e University of Georgia, 2001.
21 8 PhD 19 (Microbiology) c
2f University of Virginia, 2007.
21 7 MD c
2f University of Virginia, 2009.
21 7 MS 24 (Translational Research ) c
1d Penn, 2018.
c
3
3
21
21 7 BS 4f (Interdisciplinary Studies: Neurology - Magna cum laude with Honors) c
2e University of Georgia, 2001.
21 8 PhD 19 (Microbiology) c
2f University of Virginia, 2007.
21 7 MD c
2f University of Virginia, 2009.
21 7 MS 24 (Translational Research ) c
1d Penn, 2018.
c
1f
Post-Graduate Training
24 5a Pediatric Residency, The Children's Hospital of Philadelphia, 2009-2011.
24 93 Child Neurology Residency, The Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania, 2011-2014.
24 7f Multiple Sclerosis and Demyelinating Diseases Fellowship, The Children's Hospital of Philadelphia, 2015-2016.
24 57 Lysosomal Disease Network (LDN) research fellowship, CHOP, 2017-2018.
c
3
25
24 5a Pediatric Residency, The Children's Hospital of Philadelphia, 2009-2011.
24 93 Child Neurology Residency, The Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania, 2011-2014.
24 7f Multiple Sclerosis and Demyelinating Diseases Fellowship, The Children's Hospital of Philadelphia, 2015-2016.
24 57 Lysosomal Disease Network (LDN) research fellowship, CHOP, 2017-2018.
c
17
Certifications
28 43 American Board of Psychiatry and Neurology, 2014.
c
3
8d
Permanent link28 43 American Board of Psychiatry and Neurology, 2014.
c
2 29
21
1e
1d
24
5e
71
e 29
27
Description of Clinical Expertise
20 Leukodystrophies71
Description of Research Expertise
4e Clinical and biologic outcome measures in the leukodystrophiese 29
23
222 Asbreuk MABC, Schoenmakers DH, Adang LA, Beerepoot S, Bergner C, Bley A, Boelens JJ, Bugiani M, Calbi V, García-Cazorla À, Eklund EA, Fumagalli F, Grønborg SW, Groeschel S, Van Hasselt PM, Hollak CEM, Jones SA, de Koning TJ, van Kuilenburg ABP, Laugwitz L, Lindemans C, Mochel F, Øberg A, Ram D, Schöls L, Sevin C, Sinha J, Vaz FM, Zerem A, Wolf NI.: Metachromatic Leukodystrophy: New Therapy Advancements and Emerging Research Directions. Neurology 105(2), July 2025.
20c Kotes ER, Woidill S, D'Aiello R, Khan A, McCann J, Ramos M, Gavazzi F, Keller S, Van Haren K, Fatemi A, Eichler F, Bonkowsky J, Fraser J, Emrick L, Sherbini O, Hackett A, Gauna J, Amos D, Goodman J, Fine AS, Nagy A, Lee S, Page N, Schmidt J, Pizzino A, Muirhead K, Bennett M, Waldman A, Shults J, Adang L, Grundmeier R, Vanderver A.: Clinically Important Endpoints in Individuals With Leukodystrophy: A Multisite Study. Ann Child Neurol Soc July 2025.
fd Mohajer A, Sevagamoorthy A, Bean K, Mutua S, Pang F, Adang LA.: Characterizing Diagnostic Delays in Metachromatic Leukodystrophy: A Real-World Data Approach. JIMD 48(4), July 2025.
13b Gavazzi F, Martin A, Sevagamoorthy A, Vaia Y, Vincent A, Woidill S, D'Aiello R 3rd, DeMauro SB, Lorch SA, Vanderver A, Adang LA.: Experiences and Hope in Caregivers of Children With Aicardi Goutières Syndrome. J Child Neurology 22, May 2025.
2bc Schoenmakers DH, Asbreuk MABC, Martin T, Datema M, Beerepoot S, Inbar-Feigenberg M, Groeschel S, Kehrer C, Øberg A, Sevin C, Fumagalli F, Bergner CG, Vieira P, Bley A, Uusimaa J, Horn MA, Brožová K, Stögmann E, Pichler H, Lüftinger R, Eklund EA, Mochel F, Adang LA, Laugwitz L, Boelens JJ, Calbi V, Darling A, García-Cazorla Á, Grønborg SW, Lindemans CA, van Hasselt PM, Hollak CEM, de Koning TJ, Ram D, Dekker H, Schöls L, Zerem A, Graessner H, Wolf NI.: Key lessons from the first international treatment eligibility committee: the case of metachromatic leukodystrophy. Eur J Paediatr Neurol 29(57): 72-81, May 2025.
181 Gavazzi F, Yu E, Tashnim Z, Woidill S, Sevagamoorthy A, Arnold K, Ammann-Schnell L, Groeschel S, Krägeloh-Mann I, Breitling V, Schlotawa L, Ahrens-Nicklas R, Adang LA.: Exploration Into Lived Experiences of Multiple Sulfatase Deficiency-Affected Individuals and Their Families. J. Child Neurology(14), May 2025.
1ea Dominguez Gonzalez CA, Spinner NB, Ahrens-Nicklas RC, Young LR, Voss LA, Reichert SL, Gallo DJ, Cohen JS, Bonkowsky JL, Keller SR, Bennett ML, Pizzino AM, Swantkowski M, Arnold K, Fraser JL, Emerson FJ, Miettunen K, Fatemi A, Van Haren KP, Adang L, Waldman A, Emrick L, Eichler F, Vanderver A.: Reporting ABCD1 Variants as Actionable Secondary Findings on Exome and Genome Sequencing. Genet Med 5(101425), April 2025.
2cb Gavazzi F, Charsar B, Hamilton E, Erler JA, Patel V, Woidill S, Sevagamoorthy A, Helman G, Schmidt J, Pizzino A, Muirhead K, Takanohashi A, Bonkowsky JL, Meyerhoffer K, Simons C, Doi H, Satoko M, Matsumoto N, Delgado MR, Sanchez-Castillo M, Wang J, de Carvalho DR, Tournev I, Chamova T, Jordanova A, Clegg NJ, Nicita F, Bertini E, Teng M, Williams D, Tonduti D, Houlden H, Stellingwerff M, Wassmer E, Garcia-Cazorla A, Bernard G, Mirchi A, Toutounchi H, Wolf NI, van der Knaap MS, Shults J, Adang LA, Vanderver AL.: The natural history of variable subtypes in pediatric-onset TUBB4A-related leukodystrophy. Mol Genet Metab 144(3), March 2025.
157 Kotes E, Gavazzi F, Woidill S, Sevagamoorthy A, Yang E, Smith V, Dubbs H, Pierce SR, Pucci K, Vithayathil J, Thakur N, Adang LA: Determination of Health Concepts in β-Propeller Protein-Associated Neurodegeneration. Journal of Child Neurology 40(1): 15-25, January 2025.
2c
7
1d
1f
Selected Publications
252 Varesio C, Politano D, Adang L, Ballante E, Battini R, Bertini E, Borgatti R, De Giorgis V, Del Boca A, Dragoni F, Fazzi E, Galli J, Garau J, Gavazzi F, Gardani A, La Piana R, Moroni I, Nicita F, Pichiecchio A, Pini A, Ricci F, Sartori S, Tonduti D, Vanderver A, Orcesi S.: Clinical Characterization of a Multicenter International Cohort of Patients With Aicardi-Goutières Syndrome Homozygous for the RNASEH2B:p.Ala177Thr Variant: Early Clinical Markers of Disease Severity. Pediatric Neurology 171: 92-99, October 2025.222 Asbreuk MABC, Schoenmakers DH, Adang LA, Beerepoot S, Bergner C, Bley A, Boelens JJ, Bugiani M, Calbi V, García-Cazorla À, Eklund EA, Fumagalli F, Grønborg SW, Groeschel S, Van Hasselt PM, Hollak CEM, Jones SA, de Koning TJ, van Kuilenburg ABP, Laugwitz L, Lindemans C, Mochel F, Øberg A, Ram D, Schöls L, Sevin C, Sinha J, Vaz FM, Zerem A, Wolf NI.: Metachromatic Leukodystrophy: New Therapy Advancements and Emerging Research Directions. Neurology 105(2), July 2025.
20c Kotes ER, Woidill S, D'Aiello R, Khan A, McCann J, Ramos M, Gavazzi F, Keller S, Van Haren K, Fatemi A, Eichler F, Bonkowsky J, Fraser J, Emrick L, Sherbini O, Hackett A, Gauna J, Amos D, Goodman J, Fine AS, Nagy A, Lee S, Page N, Schmidt J, Pizzino A, Muirhead K, Bennett M, Waldman A, Shults J, Adang L, Grundmeier R, Vanderver A.: Clinically Important Endpoints in Individuals With Leukodystrophy: A Multisite Study. Ann Child Neurol Soc July 2025.
fd Mohajer A, Sevagamoorthy A, Bean K, Mutua S, Pang F, Adang LA.: Characterizing Diagnostic Delays in Metachromatic Leukodystrophy: A Real-World Data Approach. JIMD 48(4), July 2025.
13b Gavazzi F, Martin A, Sevagamoorthy A, Vaia Y, Vincent A, Woidill S, D'Aiello R 3rd, DeMauro SB, Lorch SA, Vanderver A, Adang LA.: Experiences and Hope in Caregivers of Children With Aicardi Goutières Syndrome. J Child Neurology 22, May 2025.
2bc Schoenmakers DH, Asbreuk MABC, Martin T, Datema M, Beerepoot S, Inbar-Feigenberg M, Groeschel S, Kehrer C, Øberg A, Sevin C, Fumagalli F, Bergner CG, Vieira P, Bley A, Uusimaa J, Horn MA, Brožová K, Stögmann E, Pichler H, Lüftinger R, Eklund EA, Mochel F, Adang LA, Laugwitz L, Boelens JJ, Calbi V, Darling A, García-Cazorla Á, Grønborg SW, Lindemans CA, van Hasselt PM, Hollak CEM, de Koning TJ, Ram D, Dekker H, Schöls L, Zerem A, Graessner H, Wolf NI.: Key lessons from the first international treatment eligibility committee: the case of metachromatic leukodystrophy. Eur J Paediatr Neurol 29(57): 72-81, May 2025.
181 Gavazzi F, Yu E, Tashnim Z, Woidill S, Sevagamoorthy A, Arnold K, Ammann-Schnell L, Groeschel S, Krägeloh-Mann I, Breitling V, Schlotawa L, Ahrens-Nicklas R, Adang LA.: Exploration Into Lived Experiences of Multiple Sulfatase Deficiency-Affected Individuals and Their Families. J. Child Neurology(14), May 2025.
1ea Dominguez Gonzalez CA, Spinner NB, Ahrens-Nicklas RC, Young LR, Voss LA, Reichert SL, Gallo DJ, Cohen JS, Bonkowsky JL, Keller SR, Bennett ML, Pizzino AM, Swantkowski M, Arnold K, Fraser JL, Emerson FJ, Miettunen K, Fatemi A, Van Haren KP, Adang L, Waldman A, Emrick L, Eichler F, Vanderver A.: Reporting ABCD1 Variants as Actionable Secondary Findings on Exome and Genome Sequencing. Genet Med 5(101425), April 2025.
2cb Gavazzi F, Charsar B, Hamilton E, Erler JA, Patel V, Woidill S, Sevagamoorthy A, Helman G, Schmidt J, Pizzino A, Muirhead K, Takanohashi A, Bonkowsky JL, Meyerhoffer K, Simons C, Doi H, Satoko M, Matsumoto N, Delgado MR, Sanchez-Castillo M, Wang J, de Carvalho DR, Tournev I, Chamova T, Jordanova A, Clegg NJ, Nicita F, Bertini E, Teng M, Williams D, Tonduti D, Houlden H, Stellingwerff M, Wassmer E, Garcia-Cazorla A, Bernard G, Mirchi A, Toutounchi H, Wolf NI, van der Knaap MS, Shults J, Adang LA, Vanderver AL.: The natural history of variable subtypes in pediatric-onset TUBB4A-related leukodystrophy. Mol Genet Metab 144(3), March 2025.
157 Kotes E, Gavazzi F, Woidill S, Sevagamoorthy A, Yang E, Smith V, Dubbs H, Pierce SR, Pucci K, Vithayathil J, Thakur N, Adang LA: Determination of Health Concepts in β-Propeller Protein-Associated Neurodegeneration. Journal of Child Neurology 40(1): 15-25, January 2025.
2c